Wall Street Ends Higher On Speculation About End To Iran War Reuters 20260401 1 Is Caterpillar Cat Stock Showing Strength Price At 788.81 Down 0.23 20260413 Is Ryerson Ryz Stock Near Resistance Price At 24.79 Up 0.61 20260413 Is Delta Air Dal Stock In An Uptrend Price At 66.69 Down 0.10 20260406 Is Kelly Services KELYA stock trading below fair range Eye on Rally 20260418 NOVTU Novanta Inc Tangible Equity Units notches narrow Q4 2025 EPS beat shares fall 125 percent in todays trading VELO Velo3D misses Q4 2025 earnings by 787 yet shares surge 10 as investors embrace growth outlook Yimutian YMT Stock Why Barrier to Entry In Focus 20260416 Port of Los Angeles Box Volume Climbs 57 Signaling Resilient Trade Activity Trumps Beijing Visit State Banquets Business Dealmaking and Selfies with Musk Xi Warns Trump Mishandling Taiwan Could Put USChina Relations in Great Jeopardy SBA Doubles Cumulative 7a and 504 Loan Limits to 10 Million Zscaler Partners with Anthropic and OpenAI as Quarterly Revenue Surges 25 Market Recap 10 Key Factors Shaping Stock Trading on Wednesday Indias Labor Market Under Pressure as Iran Conflict Disrupts Remittances and Trade Trump Signals No Rush on Iran Nuclear Deal Criticizes Opponents as Losers Broadcom Engages EU Regulatory Challenges While Barclays Highlights AI Growth Potential Northland Boosts Price Target on Synaptics SYNA What Investors Should Know Singapore April Inflation Misses Expectations at 18 Growth Forecast Revised Upward CorVel Q4 2026 Earnings Call Transcript Released Management Discusses Quarterly Performance and Strategic Direction S Q1 2026 Earnings EPS Surprises to the Upside Shares Edge Higher LBRDA Q3 2025 Earnings Strong EPS Beat Boosts Investor Sentiment American Resources Corporation AREC Q3 2025 Earnings Narrowing Losses Beat Estimates Amid Quiet Revenue Disclosure XOMA Q1 2026 Earnings Royalty Revenue Shortfall Pushes EPS Below Estimates Jeff Bezos Predicts AI Will Elevate Jobs Using Bulldozer Instead of Shovel Metaphor CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline